Strategies for disease modification in Alzheimer's disease

@article{Citron2004StrategiesFD,
  title={Strategies for disease modification in Alzheimer's disease},
  author={Martin O. Citron},
  journal={Nature Reviews Neuroscience},
  year={2004},
  volume={5},
  pages={677-685}
}
Treating Alzheimer's disease (AD) is the biggest unmet medical need in neurology. Current drugs improve symptoms, but do not have profound disease-modifying effects. Three main classes of disease-modification approaches can be defined: one that is broadly neurotrophic or neuroprotective, one that targets specific aspects of AD pathology, and one that is based on epidemiological observation. This review discusses all three approaches, with particular emphasis on anti-amyloid strategies… CONTINUE READING
BETA

Figures and Topics from this paper.

Explore Further: Topics Discussed in This Paper

Citations

Publications citing this paper.
SHOWING 1-10 OF 188 CITATIONS

FILTER CITATIONS BY YEAR

2005
2019

CITATION STATISTICS

  • 14 Highly Influenced Citations

  • Averaged 11 Citations per year over the last 3 years

References

Publications referenced by this paper.
SHOWING 1-10 OF 104 REFERENCES

Alzheimer ’ s diseaseaffected brain : presence of oligomeric A β ligands ( ADDLs ) suggests a molecular basis for reversible memory loss

  • Y. Gong
  • Proc . Natl Acad . Sci . USA
  • 2003

Similar Papers

Loading similar papers…